Cargando…
Measuring disease activity and severity in clinical trials and the clinic: same or different?
Autor principal: | Petri, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891553/ http://dx.doi.org/10.1186/ar4222 |
Ejemplares similares
-
Clinical response to belimumab in academic clinical practices
por: Reddy, Arthi, et al.
Publicado: (2014) -
Important factors for the modelling and design of clinical trials for severe sepsis and multiple organ failure
por: Shaikh, L, et al.
Publicado: (1999) -
SIRS in ICU: a different approach in sepsis assessment: clinical predictivity, severity scores, costs
por: Oggioni, R, et al.
Publicado: (1997) -
Review of clinical trials
por: Hendrick, RE
Publicado: (2002) -
Phagocytic activity of monocytes in patients with breast cancer at different clinical stages
por: Arsenijevic, NN, et al.
Publicado: (2001)